PMC:7534795 / 7019-7311 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T56","span":{"begin":25,"end":33},"obj":"Disease"},{"id":"T57","span":{"begin":174,"end":182},"obj":"Disease"},{"id":"T58","span":{"begin":268,"end":280},"obj":"Disease"}],"attributes":[{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":"E2 receptors lost due to COVID-19 (Akhmerov \u0026 Marban, 2020)\nN-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications\n• Suggested role for NAC in prevention of hypertension, atheroscle"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T62","span":{"begin":60,"end":76},"obj":"Chemical"},{"id":"T63","span":{"begin":62,"end":76},"obj":"Chemical"},{"id":"T64","span":{"begin":78,"end":81},"obj":"Chemical"},{"id":"T66","span":{"begin":90,"end":97},"obj":"Chemical"},{"id":"T67","span":{"begin":134,"end":137},"obj":"Chemical"},{"id":"T69","span":{"begin":153,"end":161},"obj":"Chemical"},{"id":"T70","span":{"begin":247,"end":250},"obj":"Chemical"}],"attributes":[{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_28939"},{"id":"A63","pred":"chebi_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/CHEBI_22198"},{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_28939"},{"id":"A65","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_7421"},{"id":"A66","pred":"chebi_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/CHEBI_63248"},{"id":"A67","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_28939"},{"id":"A68","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_7421"},{"id":"A69","pred":"chebi_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A70","pred":"chebi_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/CHEBI_28939"},{"id":"A71","pred":"chebi_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/CHEBI_7421"}],"text":"E2 receptors lost due to COVID-19 (Akhmerov \u0026 Marban, 2020)\nN-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications\n• Suggested role for NAC in prevention of hypertension, atheroscle"}

{"project":"LitCovid-sentences","denotations":[{"id":"T39","span":{"begin":60,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"E2 receptors lost due to COVID-19 (Akhmerov \u0026 Marban, 2020)\nN-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications\n• Suggested role for NAC in prevention of hypertension, atheroscle"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":268,"end":280},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"E2 receptors lost due to COVID-19 (Akhmerov \u0026 Marban, 2020)\nN-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications\n• Suggested role for NAC in prevention of hypertension, atheroscle"}

{"project":"2_test","denotations":[{"id":"33031856-32252591-84038812","span":{"begin":54,"end":58},"obj":"32252591"}],"text":"E2 receptors lost due to COVID-19 (Akhmerov \u0026 Marban, 2020)\nN-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications\n• Suggested role for NAC in prevention of hypertension, atheroscle"}